The model layer
A curated catalogue of frontier open-weight models, validated for healthcare and version-pinned. Foundation models, clinical specialists, embedders.
Adding a model is harder than removing one.
Where intelligence is allowed.
Bifrost runs frontier open-weight AI models inside sovereign healthcare environments. The clinical record never leaves its jurisdiction. The intelligence it produces does.
For a decade the cloud told healthcare one story. Keep the data in the jurisdiction. Keep it still. Keep it safe. Sovereignty as a wall, a cost, a box ticked so the regulator looks away.
Read it the other way. Frontier AI has the scale and the compute, and it is barred, by law, from the one archive that would make it clinically useful: the patient’s own record. The public cloud can read almost everything, except the thing that matters most.
Health data is more than 30% of the world’s data. Less than 3% of it is ever put to use beyond the visit that created it. Not because the data is poor, but because the places large enough to compute on it are the places forbidden to hold it.
Source / EHDS secondary-use framing · European Commission · Frontiers in Digital Health, 2025
Sovereign AI is simple to state. Take the strongest frontier open-weight models available, and run them inside the jurisdiction, on the real clinical record, where the data already lives. The model comes to the data. Nothing leaves the boundary but the answer.
Defensive sovereignty keeps the record still and safe, and everyone now claims it. This is the next move: the same boundary, made to produce. The record stays; the intelligence travels. Call it generative sovereignty, and the public cloud cannot follow, because its entire design is to pull your data to its compute. Bifrost does the opposite.
Inside the sovereign boundary sits The Keep, the sovereign AI stack: a curated catalogue of frontier open-weight models, retrieval over the clinical record, and sovereign inference, operated as one unit. The Keep holds the model and the record inside the wall. The bridge carries the insight across, never the record.
These three layers are The Keep: the models, the clinical context they reason over, and the sovereign ground they run on. A builder composes against them. The platform is operated; the application is theirs.
A curated catalogue of frontier open-weight models, validated for healthcare and version-pinned. Foundation models, clinical specialists, embedders.
Adding a model is harder than removing one.
Per-tenant retrieval over the clinical record, fused with the model inside the perimeter. Notes, imaging, labs and medications, grounded in the standard ontologies and encrypted under tenant keys.
AI without context is guesswork.
Sovereign GPU and inference across six jurisdictions, operated by 3verest: deployment, compliance evidence, observability, lifecycle. You build the application. The line is drawn deliberately.
The bridge holds wherever it is built.
Bifrost does not build the application. It builds The Keep, the platform the application runs on. Providers build for their own clinicians. Vendors ship it inside what they sell. The customer relationship, and the clinical outcome, stays theirs.
Health systems · hospital groups · integrated networks
Build clinical AI for your own clinicians: discharge summaries, radiology triage, sepsis early warning. You own the application, the workflow and the patient relationship. Bifrost operates the platform underneath.
Build the application. The platform is already managed.
EHR · PACS · VNA · RIS · LIS · ISVs · integrators
Ship sovereign AI inside the products you sell, embedded or white-labelled. Your customers inherit the sovereignty, the jurisdiction discipline and the evidence chain. You compete on workflow; the platform is handled.
Ship the feature. The compliance came with it.
Inside the boundary, the archive stops being a cost to defend and becomes an asset that works.
Reads drafted against priors the model has actually seen.
Research-grade evidence assembled without a single record leaving the jurisdiction.
Real-world evidence that pharma and regulators can trust, because its provenance never left sovereign ground.
The wall is the reason, not the obstacle.